The global perfusion systems market is largely fueled by the increasing prevalence of cardiovascular disorders and the growing number of cardiac surgeries performed worldwide. In addition, the rising cases of organ failure, including kidney, liver, heart, and lung failure, have significantly increased the number of organ transplant procedures, thereby driving greater demand for advanced perfusion technologies.
New York, USA, April 23, 2026 (GLOBE NEWSWIRE) — Global Perfusion Systems Market to Register Incremental Growth at a CAGR of ~5% by 2034 | DelveInsight
The global perfusion systems market is largely fueled by the increasing prevalence of cardiovascular disorders and the growing number of cardiac surgeries performed worldwide. In addition, the rising cases of organ failure, including kidney, liver, heart, and lung failure, have significantly increased the number of organ transplant procedures, thereby driving greater demand for advanced perfusion technologies.
DelveInsight’s Perfusion Systems Market Insights report provides the current and forecast market analysis, individual leading perfusion systems companies’ market shares, challenges, perfusion systems market drivers, barriers, trends, and key perfusion systems companies in the market.
Perfusion Systems Market Summary
- 2025 Perfusion Systems Market Size: USD 1.5 Billion
- 2034 Projected Perfusion Systems Market Size: USD 2.4 Billion
- Perfusion Systems Market Growth Rate (2026-2034): ~5%
- Largest Perfusion Systems Market: North America
- Largest Product Type Segment: Cardiopulmonary Bypass Systems Category within the System Segment
- Key Companies in the Perfusion Systems Market: LivaNova PLC, TransMedica, Inc., Medtronic, Organ Recovery Systems, Inc., Transmedics Inc., Terumo Corporation, XVIVO Perfusion AB, Visionary Medicare Solutions Pvt Ltd., Bridge to Life Ltd., Ala Scientific Instruments Inc., Quantum Technologies, Cytiva, Harvard Apparatus, Pedra Technology Pte Ltd., Getinge AB, Vascular Perfusion Solutions, Inc., Paragonic Technologies, Eurosets S.r.l, Soma Tech Intl, Repligen Corporation, and others
To read more about the latest highlights related to the perfusion systems market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/perfusion-systems-market
Key Factors Contributing to the Rise in Growth of the Perfusion Systems Market
- Rising Prevalence of Cardiovascular Diseases: Cardiovascular diseases remain the single largest demand driver for perfusion systems. The steady global increase in heart disease, strokes, and coronary artery disease directly increases the number of cardiac surgeries, such as coronary artery bypass grafting (CABG) and heart valve procedures, that require cardiopulmonary bypass systems.
- Surge in Organ Transplantation Procedures: The growing incidence of multi-organ failure, driven by cardiovascular, respiratory, renal, and hepatic disorders, is fueling a parallel surge in organ transplantation.
- Technological Innovations and AI Integration: Continuous advancements in perfusion technology are broadening its clinical applications and improving outcomes.
- Growing Aging Population: An aging global population is a structural tailwind for the market, as older patients require frequent life-supporting treatments, including organ transplantation and critical care surgeries.
- Expansion of Biopharmaceutical R&D: Beyond surgical applications, biopharmaceutical manufacturing is emerging as a significant growth opportunity.
- Government Support and Healthcare Infrastructure Investment: Favorable government policies and increased healthcare spending have provided robust structural support to the market.
- Shift Toward Minimally Invasive Surgeries: The global shift toward minimally invasive surgical procedures is increasing demand for compact and portable perfusion technologies.
Get a sneak peek at the perfusion systems market dynamics @ Perfusion Systems Market Trends
Regional Perfusion Systems Market Insights
North America
- North America held the largest share of the Perfusion Systems market in 2025, representing 41% of the global market across all regions.
- This leading position is supported by the increasing number of organ failure cases and transplant procedures, the rising burden of cardiovascular and respiratory diseases, and ongoing technological progress in ex vivo organ preservation systems.
Europe
- In Europe, the perfusion systems market is expanding, driven by the increasing incidence of organ failure, a growing number of transplantation procedures, and the high burden of cardiovascular and respiratory disorders.
- Continuous advancements in ex vivo organ preservation technologies, which enhance organ viability and prolong preservation duration, are also contributing to market growth.
Asia-Pacific
- In the Asia Pacific region, the perfusion systems market is expanding, driven by the increasing incidence of organ failure, a rise in transplant procedures, and the growing burden of cardiovascular and respiratory disorders.
- Additionally, advancements in ex vivo organ preservation technologies are further accelerating market growth.
To know more about why North America is leading the market growth in the perfusion systems market, get a snapshot of the Perfusion Systems Market Share
Recent Developmental Activities in the Perfusion Systems Market
- In January 2026, Bridge to Life Ltd. secured U.S. Food and Drug Administration (FDA) De Novo clearance for its VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, becoming the first device cleared in the United States for hypothermic oxygenated perfusion of donor livers.
- In September 2025, OrganOx Ltd., the organ technology company focused on addressing complex transplant challenges, announced that its metra® normothermic machine perfusion (NMP) device had received approval from the U.S. Food and Drug Administration (FDA) for operation during air transport.
What are Perfusion Systems?
Perfusion systems are specialized medical devices designed to circulate blood or oxygenated fluids through the body or specific organs when natural physiological functions are impaired or temporarily stopped. Commonly used during complex surgeries such as cardiac procedures, organ transplantation, and critical care management, these systems help maintain tissue oxygenation, nutrient delivery, and waste removal. They typically include pumps, oxygenators, tubing circuits, heat exchangers, and monitoring components that work together to regulate blood flow, temperature, and gas exchange. Perfusion systems are also increasingly used in extracorporeal life support therapies such as ECMO (Extracorporeal Membrane Oxygenation) and in organ preservation technologies, where they sustain donor organs outside the body before transplantation. By ensuring continuous circulation and organ support, perfusion systems play a vital role in modern surgical and intensive care settings.
| Perfusion Systems Market Report Metrics | Details |
| Coverage | Global |
| Study Period | 2023–2034 |
| Perfusion Systems Market CAGR | ~5% |
| Perfusion Systems Market Size by 2034 | USD 2.4 Billion |
| Key Perfusion Systems Companies | LivaNova PLC, TransMedica, Inc., Medtronic, Organ Recovery Systems, Inc., Transmedics Inc., Terumo Corporation, XVIVO Perfusion AB, Visionary Medicare Solutions Pvt Ltd., Bridge to Life Ltd., Ala Scientific Instruments Inc., Quantum Technologies, Cytiva, Harvard Apparatus, Pedra Technology Pte Ltd., Getinge AB, Vascular Perfusion Solutions, Inc., Paragonic Technologies, Eurosets S.r.l, Soma Tech Intl, Repligen Corporation, and others |
Perfusion Systems Market Assessment
- Perfusion Systems Market Segmentation
- Perfusion Systems Market Segmentation By Product Type: System {Cardiopulmonary Bypass Perfusion Systems, Extracorporeal Membrane Oxygenation (ECMO) System, Organ Perfusion Systems [Hypothermic Perfusion Systems and Normothermic Perfusion system]}, Component {Oxygenator, Reservoir, Centrifugal Pumps, and Others}, and Consumables & Accessories
- Perfusion Systems Market Segmentation By Application: Cardiac Surgery, Organ Preservation, Respiratory Support, and Others
- Perfusion Systems Market Segmentation By End User: Hospitals, Transplant Centers, and Others
- Perfusion Systems Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the perfusion systems market are set to emerge as the trendsetter explore @ Perfusion Systems Market Analysis
Table of Contents
| 1 | Perfusion Systems Market Report Introduction |
| 2 | Perfusion Systems Market Executive Summary |
| 3 | Perfusion Systems Market Key Factors Analysis |
| 4 | Impact Analysis |
| 5 | Regulatory Analysis |
| 6 | Perfusion Systems Market Porter’s Five Forces Analysis |
| 7 | Perfusion Systems Market Assessment |
| 8 | Competitive Landscape |
| 9 | Startup Funding & Investment Trends |
| 10 | Perfusion Systems Market Company and Product Profiles |
| 11 | KOL Views |
| 12 | Project Approach |
| 13 | About DelveInsight |
| 14 | Disclaimer & Contact Us |
Interested in knowing the perfusion systems market share by 2034? Click to get a snapshot of the Perfusion Systems Market Size
Related Reports
Cardiopulmonary Bypass Equipment Market
Cardiopulmonary Bypass Equipment Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiopulmonary bypass equipment companies, including Medtronic plc., LivaNova PLC, MAQUET Holding B.V. & Co. KG., ABIOMED, Braile Biomedica Ltda, Tianjin Medical, Terumo Corp, Senko Medical Instrument Manufacturing Co., Ltd., Technowood Corp, Sorin, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, OriGen Biomedical, Thoratec Corporation, Inspira Technologies OXY B.H.N. Ltd., Xenios AG, Boston Scientific, Cardinal Health, B. Braun, and others.
Extracorporeal Membrane Oxygenation Devices Market
Extracorporeal Membrane Oxygenation Devices Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key extracorporeal membrane oxygenation devices companies, including Getinge Group, Medtronic, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical, Inc., EUROSETS S.r.l., ALung Technologies, Inc., Medos Medizintechnik AG, Abiomed, Novalung, Senko Medical Instrument Manufacturing Co. Ltd., Braile Biomedica Ltd., Sorin, Thoratec Corporation, MAQUET Holding B.V. & Co. KG., Tianjin Medical, SHANDONG WEGO NEW LIFE MEDICAL DEVICES CO., LTD., and others.
Oxygenators Market
Oxygenators Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key oxygenators companies, including Chalice Medical Ltd., EUROSETS, Getinge AB., LivaNova PLC, Medtronic, Kewei Medical, Terumo Europe NV, Braile Biomédica, XENIOS AG, Fresenius Medical Care AG & Co. KGaA, MC3 Cardiopulmonary, Gen World Medical Devices., MERA, Owgels, NIPRO Medical Corporation, and others.
Chronic Obstructive Pulmonary Disease Treatment Devices Market
Chronic Obstructive Pulmonary Disease Treatment Devices Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key COPD treatment devices companies, including Koninklijke Philips N.V., Omron Healthcare, Inc., Aerogen, GF Health Products, Inc., BMC Medical Co., Ltd., Medtronic, Trudell Medical International, Novartis AG, AstraZeneca, Lupin, Zydus Cadila, Teva Pharmaceutical Industries Ltd, Terumo Corporation, Cipla Inc., Microlife Corporation, Honsun, Promed Technology Co. Limited, HELTMAN Medikal A.S., Pneuma Respiratory, Lepu Medical Technology (Beijing) Co., Ltd., and others.
Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key COPD companies including Genentech, Inc., GlaxoSmithKline, Verona Pharma plc, Regeneron Pharmaceuticals, Sanofi, MedImmune LLC, EpiEndo Pharmaceuticals, Tetherex Pharmaceuticals, AstraZeneca, Chiesi Farmaceutici S.p.A., Synairgen Research Ltd., Mereo Biopharma, Organicell Regenerative Medicine, Pulmotect, Inc., Inmunotek S.L., PULMATRiX, GLENMARK PHARMACEUTICALS LTD, Dimerix Limited, ProterixBio, and others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
CONTACT: Contact Us Shruti Thakur info@delveinsight.com +14699457679